Three months ago, antitrust authorities in Italy fined Novartis and Roche $251 million on charges they colluded to protect sales of their eye drug, Lucentis. Now, that country's Health Ministry is seeking further damages.
written on 29.05.2014
Roche, Novartis face $1.6B in damages on Italy's Lucentis collusion ruling
